These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 747914)

  • 21. Light-induced racemization: artifacts in the analysis of the diastereoisomeric pairs of thioridazine 5-sulfoxide in the plasma and urine of patients treated with thioridazine.
    Eap CB; Souche A; Koeb L; Baumann P
    Ther Drug Monit; 1991 Jul; 13(4):356-62. PubMed ID: 1780970
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Successful suicides with thioridazine and mesoridazine: a result of probable cardiotoxicity.
    Donlon PT; Tupin JP
    Arch Gen Psychiatry; 1977 Aug; 34(8):955-7. PubMed ID: 889420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Blood levels of haloperidol and thioridazine during maintenance neuroleptic treatment of schizophrenic outpatients.
    Shvartsburd A; Sajadi C; Morton V; Mirabi M; Gordon J; Smith RC
    J Clin Psychopharmacol; 1984 Aug; 4(4):194-8. PubMed ID: 6470190
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Measurement of thioridazine in blood and urine.
    Ng CH; Crammer JL
    Br J Clin Pharmacol; 1977 Apr; 4(2):173-83. PubMed ID: 16633
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Determination of the enantiomers of thioridazine, thioridazine 2-sulfone, and of the isomeric pairs of thioridazine 2-sulfoxide and thioridazine 5-sulfoxide in human plasma.
    Eap CB; Koeb L; Powell K; Baumann P
    J Chromatogr B Biomed Appl; 1995 Jul; 669(2):271-9. PubMed ID: 7581903
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A fixed dose study of the plasma concentration and clinical effects of thioridazine and its major metabolites.
    Cohen BM; Lipinski JF; Waternaux C
    Psychopharmacology (Berl); 1989; 97(4):481-8. PubMed ID: 2498945
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma levels and half lives of thioridazine and some of its metabolites. II. Low doses in older psychiatric patients.
    Muusze RG; Vanderheeren FA
    Eur J Clin Pharmacol; 1977 Jan; 11(2):141-7. PubMed ID: 837967
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Concentrations of thioridazine and thioridazine metabolites in erythrocytes.
    Svensson C; Nyberg G; Axelsson R; Mårtensson E
    Psychopharmacology (Berl); 1986; 89(3):291-2. PubMed ID: 3088651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Single dose kinetics of thioridazine and its two psychoactive metabolites in healthy humans: a dose proportionality study.
    Chakraborty BS; Midha KK; McKay G; Hawes EM; Hubbard JW; Korchinski ED; Choc MG; Robinson WT
    J Pharm Sci; 1989 Oct; 78(10):796-801. PubMed ID: 2600782
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metabolism of thioridazine in the elderly.
    Cohen BM; Sommer BR
    J Clin Psychopharmacol; 1988 Oct; 8(5):336-9. PubMed ID: 3183071
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma levels and half lives of thioridazine and some of its metabolites. I. High doses in young acute schizophrenics.
    Vanderheeren FA; Muusze RG
    Eur J Clin Pharmacol; 1977 Jan; 11(2):135-40. PubMed ID: 320014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gas-liquid chromotographic determination of perazine, thioridazine and thioridazine metabolites in human plasma.
    Vanderheeren FA; Theunis DJ
    J Chromatogr; 1976 May; 120(1):123-8. PubMed ID: 5459
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Concentration-related pharmacodynamic effects of thioridazine and its metabolites in humans.
    Hartigan-Go K; Bateman DN; Nyberg G; Mårtensson E; Thomas SH
    Clin Pharmacol Ther; 1996 Nov; 60(5):543-53. PubMed ID: 8941027
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of phenothiazine neuroleptics after chronic coadministration of carbamazepine.
    Daniel WA; Syrek M; Haduch A; Wójcikowski J
    Pol J Pharmacol; 1998; 50(6):431-42. PubMed ID: 10385926
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Haloperidol and thioridazine drug levels and clinical response in schizophrenia: comparison of gas-liquid chromatography and radioreceptor drug level assays.
    Smith RC; Baumgartner R; Burd A; Ravichandran GK; Mauldin M
    Psychopharmacol Bull; 1985; 21(1):52-8. PubMed ID: 3983338
    [No Abstract]   [Full Text] [Related]  

  • 36. Greater potency of mesoridazine and sulforidazine compared with the parent compound, thioridazine, on striatal dopamine autoreceptors.
    Niedzwiecki DM; Mailman RB; Cubeddu LX
    J Pharmacol Exp Ther; 1984 Mar; 228(3):636-9. PubMed ID: 6707914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasma concentrations of thioridazine metabolites and ECG abnormalities.
    Gottschalk LA; Dinovo E; Biener R; Nandi BR
    J Pharm Sci; 1978 Feb; 67(2):155-7. PubMed ID: 621628
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum chlordiazepoxide, diazepam and thioridazine concentrations after the simultaneous ingestion of alcohol or placebo drink.
    Linnoila M; Otterström S; Anttila M
    Ann Clin Res; 1974 Feb; 6(1):4-6. PubMed ID: 4595066
    [No Abstract]   [Full Text] [Related]  

  • 39. Cerebrospinal fluid concentrations of thioridazine and its main metabolites in psychiatric patients.
    Nyberg G; Axelsson R; Mårtensson E
    Eur J Clin Pharmacol; 1981 Jan; 19(2):139-48. PubMed ID: 7202474
    [No Abstract]   [Full Text] [Related]  

  • 40. Gas chromatographic identification of thioridazine in plasma, and a method for routine assay of the drug.
    Curry SH; Mould GP
    J Pharm Pharmacol; 1969 Oct; 21(10):674-7. PubMed ID: 4390609
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.